Bovie Medical (BVX) says Hologic to Market J-Plasma in the U.S.
On July 21, 2016, Bovie Medical (NYSEMKT: BVX) announced (http://nnw.fm/WWw3V) the signing of a sales channel partnership agreement, which takes immediate effect, with Hologic (NASDAQ: HOLX). In announcing the agreement, Bovie Medical’s CEO, Robert L. Gershon, affirmed: “We are proud to partner with a Company of Hologic’s caliber. This agreement is an important milestone in our strategy to scale J-Plasma® through select sales channel partnerships across multiple specialties that represent large addressable market opportunities.” J-Plasma® will initially be added to Hologic’s world-class portfolio of healthcare solutions in gynecological and gynecological/oncological surgery in three U.S. regions. The agreement, which is for…